Skip to main content
. 2020 Jan 3;4:2. doi: 10.1186/s41747-019-0134-1

Fig. 4.

Fig. 4

Paradoxical acceleration of tumour growth kinetics in a patient with metastatic melanoma treated with ipilimumab and nivolumab. Baseline axial CT image and corresponding 18F-FDG PET/CT image show few perisplenic peritoneal metastatic implants. Two months after the initiation of immunotherapy, both imaging modalities show a dramatic increase in peritoneal metastases.